RFWA
MRNA icon

RPg Family Wealth Advisory’s Moderna MRNA Stock Holding History

RPg Family Wealth Advisory’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-18,240
Closed -$2.17M – 101
2024
Q2 		$2.17M Sell
18,240
-20
-0.1% -$2.53K 0.71% 46
2024
Q1 		$1.95M Buy
18,260
+361
+2% +$36.4K 0.62% 50
2023
Q4 		$1.78M Buy
+17,899
New +$1.51M 0.66% 47
2023
Q2 		– Sell
-8,178
Closed -$1.26M – 118
2023
Q1 		$1.26M Buy
8,178
+921
+13% +$152K 0.69% 47
2022
Q4 		$1.3M Sell
7,257
-109
-1% -$17.8K 0.89% 35
2022
Q3 		$974K Buy
7,366
+21
+0.3% +$3.19K 0.51% 50
2022
Q2 		$1.05M Buy
7,345
+57
+0.8% +$8.15K 0.63% 46
2022
Q1 		$1.26M Buy
7,288
+510
+8% +$85.9K 0.54% 46
2021
Q4 		$1.72M Buy
6,778
+37
+0.5% +$10.8K 0.68% 43
2021
Q3 		$2.59M Sell
6,741
-7,580
-53% -$2.8M 1.09% 28
2021
Q2 		$3.37M Buy
+14,321
New +$2.56M 1.36% 25
2020
Q4 		$2.27M Sell
21,705
-882
-4% -$89.2K 1.07% 30
2020
Q3 		$1.6M Sell
22,587
-679
-3% -$47.3K 0.84% 43
2020
Q2 		$1.49M Buy
+23,266
New +$1.27M 0.91% 44

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RPg Family Wealth Advisory's MRNA Position: Q3 2024 in Review

RPg Family Wealth Advisory sold out of Moderna (MRNA) in Q3 2024, closing a stake of 18,240 shares — an estimated $2.17M sold.

RPg Family Wealth Advisory first reported a position in MRNA in Q2 2020 and held it in 14 quarters. The position peaked at $3.37M in Q2 2021. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • RPg Family Wealth Advisory reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • RPg Family Wealth Advisory sold 18,240 Moderna shares in Q3 2024, an estimated $2.17M.
  • RPg Family Wealth Advisory first reported a position in Moderna in Q2 2020 and held it in 14 quarters.
  • RPg Family Wealth Advisory's Moderna position peaked at $3.37M in Q2 2021.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on RPg Family Wealth Advisory's 13F filing for Q3 2024, filed 5 Nov 2024.